Evening star., 1955-05-16

t1Wo AS&oeA448 W p4CSS4 APsAO4A
drugs.
Recommendation No. 8: Ad-
herence TO Priority Plan by
Physicians: Record Keeping:
That, with the cooperation Of
the medical profession pledged to
insure the success Of q voluntary
control plan, medical organiza-
tions take all appropriate steps
to assure that:
Ia Physicians will administer
vaccinations only to, and issue
prescriptions only for, children
within the priority age groups;
(b) Physicians viii, In accord
aace with the recommendations
Of the National Advisory Com
mittee on Poliomyelitis Vaccine,
keep a record Of the name Of each
child receiving a vaccination, the
age Of the child, date Of vaccina-
ton, site Of vaccination (place on
body. name Of the manufacturer
Of the vaccine used and the lot
number.
Recommendation No. 8; Record
Keeping by Distributors:
That manufacturers, pharma-
ceutical organizations. wholesale
and retail drug organizations and
States and other public agencies,
whose cooperation to make a
voluntary control plan work has
also been pledged, take necessary
steps to assure that every dis
tributor Of the vaccine keep q
record Of the name Of the manu-
facturer, the lot number, and the
customer receiving the vaccine
he handles.
Recommendation No. 10: Fed
eral Funds for Grants to States:
That legislation which has
been prepared by this depart
ment be submitted to the Con-
gress to make Federal funds
available to the States for the
purchase Of vaccine Cor in lieu
Of funds, the vaccine itself) i.
These funds must be sufficient
to pay the cost Of vaccine for
children through age 10 in low
income families. The funds
would be used after the NFP
free immunization program has
been completed and until De-
cember 81, 1866. These funds
would be paid to States upon
assurance by the State that no
child within the priority age
groups would be denied vaccina-
tions by reason Of the cost.
Recommendation No. IL: Inter.
national Supply:
That you designate q special
committee to further study
methods for assisting other ma
tions of the world.
PRINCIPLES
The principles that guided us
IN our study Of the situation.
and In our actions to date. are:
l. Safety Of the vaccine must
be the paramount consideration
and the question relating to
safety in quantity production
must be determined by the best
scientific advice, uninf1uenced by
any other factors.
2. The vaccine must be dis
tributed on an equitable basis
among the States and among
individuals within the States.
3. Children should be able to
receive the vaccine regardless of
the ability Of their parents
to pay.
4. Any distribution system
adopted must be as practical.
fast and effective as is possible
while still meeting the foregoing
principles.
CONCLUSIONS
In conclusion, we are con-
vinced that the most effective
and equitable distribution of the
vaccine will be ACCOMPLISHED
through the voluntary co-opera-
ton Of all concerned, within the
framework of existing law, for
the following reasons:
First, there are only six manu-
facturers, each Of whom has
agreed to dedicate his total out
put in accordance with an over
all plan Of division among States
developed by the Department of
Health, Education and Welfare.
Since April 81 the manufacturers
have shipped no vaccine in nor
NAL drug distribution channels.
Second, the Governors Of the
States and the State health ON
GERS can guide the intrastate al
location Of the vaccine.
Third, a wen regulated and es-
tablished channel Of distribution
already exists, into which the
vaccine not purchased for public